Oncocross Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	57,321	115,231	75,179	-	-	-
Market Cap Growth	-63.85%	53.27%	-	-	-	-
Enterprise Value	38,472	93,538	62,376	-	-	-
Last Close Price	4700.00	9580.00	6340.00	-	-	-
PS Ratio	120.64	311.05	70.12	-	-	-
PB Ratio	4.90	8.62	3.68	-	-	-
P/TBV Ratio	4.92	8.65	3.68	-	-	-
EV/Sales Ratio	80.97	252.49	58.18	-	-	-
Debt / Equity Ratio	0.72	0.40	0.03	0.01	0.05	0.20
Net Debt / Equity Ratio	-1.61	-1.35	-0.99	-1.00	-1.00	-1.08
Net Debt / EBITDA Ratio	2.36	2.25	3.08	2.59	0.70	1.70
Net Debt / FCF Ratio	2.18	1.69	3.55	3.36	0.79	1.84
Asset Turnover	0.02	0.01	0.05	0.01	0.01	0.01
Quick Ratio	3.69	4.11	11.35	15.16	4.47	7.87
Current Ratio	3.75	4.21	11.42	15.25	4.59	7.93
Return on Equity (ROE)	-61.99%	-52.79%	-35.10%	-36.33%	-114.08%	-
Return on Assets (ROA)	-20.68%	-21.43%	-21.69%	-32.76%	-53.18%	-27.13%
Return on Capital Employed (ROCE)	-33.00%	-38.00%	-33.60%	-41.30%	-146.40%	-55.20%
Earnings Yield	-16.24%	-7.75%	-8.62%	-	-	-
FCF Yield	-15.09%	-9.29%	-7.56%	-	-	-
Buyback Yield / Dilution	-10.92%	-14.17%	-17.54%	-1.44%	-63.74%	-0.83%